- Home
- PALI vs ADIL Comparison
PALI vs ADIL Comparison
Compare PALI & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PALI
- ADIL
- Stock Information
- Founded
- PALI 1996
- ADIL 2010
- Country
- PALI United States
- ADIL United States
- Employees
- PALI N/A
- ADIL N/A
- Industry
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- PALI Health Care
- ADIL Health Care
- Exchange
- PALI Nasdaq
- ADIL Nasdaq
- Market Cap
- PALI 7.5M
- ADIL 7.6M
- IPO Year
- PALI N/A
- ADIL 2018
- Fundamental
- Price
- PALI $0.60
- ADIL $0.35
- Analyst Decision
- PALI Strong Buy
- ADIL Strong Buy
- Analyst Count
- PALI 2
- ADIL 1
- Target Price
- PALI $12.00
- ADIL $8.00
- AVG Volume (30 Days)
- PALI 542.3K
- ADIL 517.7K
- Earning Date
- PALI 11-11-2025
- ADIL 11-12-2025
- Dividend Yield
- PALI N/A
- ADIL N/A
- EPS Growth
- PALI N/A
- ADIL N/A
- EPS
- PALI N/A
- ADIL N/A
- Revenue
- PALI N/A
- ADIL N/A
- Revenue This Year
- PALI N/A
- ADIL N/A
- Revenue Next Year
- PALI N/A
- ADIL N/A
- P/E Ratio
- PALI N/A
- ADIL N/A
- Revenue Growth
- PALI N/A
- ADIL N/A
- 52 Week Low
- PALI $0.53
- ADIL $0.22
- 52 Week High
- PALI $4.32
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- PALI 37.11
- ADIL 38.07
- Support Level
- PALI $0.70
- ADIL $0.36
- Resistance Level
- PALI $0.69
- ADIL $0.40
- Average True Range (ATR)
- PALI 0.04
- ADIL 0.02
- MACD
- PALI -0.00
- ADIL -0.00
- Stochastic Oscillator
- PALI 30.91
- ADIL 16.67
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.